Cartalax 20MG
$65.00
Cartalax 20MG is a 20-milligram format of Cartalax, a short peptide fragment developed in Russian peptide bioregulator research. Researchers study Cartalax in preclinical and exploratory settings related to cartilage biology, extracellular matrix signaling, and connective tissue models. Interest often focuses on how small regulatory peptides may influence gene expression patterns in cell and tissue systems.
In Stock
Cartalax 20MG is a 20-milligram format of Cartalax, a peptide fragment described in peptide bioregulator literature and explored in experimental research involving cartilage and connective tissue biology. Studies have examined Cartalax 20MG in model systems used to investigate chondrocyte activity, extracellular matrix regulation, and tissue signaling pathways, with findings generally interpreted as preliminary and context dependent.
Because Cartalax is discussed as a low molecular weight regulatory peptide, it is often used in laboratory work where researchers compare peptide fragments for their potential to modulate transcriptional responses and cell behavior in culture or ex vivo preparations. Analytical characterization commonly focuses on identity confirmation and composition rather than therapeutic intent.
- Specification: 20MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Glutathione 1500MG is a 1500-milligram format of glutathione, a naturally occurring tripeptide made of glutamate, cysteine, and glycine. Researchers study glutathione in the context of cellular redox balance and antioxidant systems. It is also investigated in models involving detoxification pathways and oxidative stress biology.
In Stock
GHK-Cu 100MG is a 100-milligram format of GHK-Cu, a copper complex of the tripeptide glycyl L histidyl L lysine. Researchers study this peptide copper complex in models of skin biology, extracellular matrix signaling, and tissue remodeling. Studies have also examined GHK-Cu in the context of wound related research and oxidative stress pathways.
In Stock
Ripex-225 225mg/ml, 10 ml is a research compound supplied in a defined concentration and volume format. Researchers may reference Ripex-225 in analytical, stability, or method development work where consistent concentration labeling is required. This product is intended for laboratory workflows that document concentration and total volume as primary identifiers.
In Stock
MT1 10Mg 10MG refers to a 10-milligram format of MT1, a melanocortin research peptide commonly associated with melanotropin analog research. Researchers study MT1 in the context of melanocortin receptor signaling, pigmentation pathways, and related neuroendocrine models.
In Stock
NAD 1000MG is a 1000-milligram format of nicotinamide adenine dinucleotide, a ubiquitous pyridine nucleotide cofactor central to cellular redox chemistry. Researchers study NAD in relation to mitochondrial metabolism, energy transfer reactions, and NAD dependent signaling pathways.
In Stock
Methenolone Enanthate 200mg/ml 10ml is a 17 beta esterified derivative of methenolone, an anabolic androgenic steroid related to dihydrotestosterone. Researchers have examined methenolone enanthate in studies involving androgen receptor activity, anabolic androgenic structure activity relationships, and ester dependent pharmacokinetics.
In Stock
Metribolone 5mg/ml 10ml is a concentration and volume format of metribolone, a synthetic anabolic androgenic steroid also known as R1881. Researchers use metribolone as a high affinity androgen receptor agonist reference compound in receptor binding and transcriptional activity studies. It is commonly handled as a laboratory standard in endocrine and molecular pharmacology research.
In Stock
MOTS-C 10MG is a 10-milligram format of MOTS-C, a 16 amino acid mitochondria-derived peptide encoded within mitochondrial 12S rRNA. Researchers study MOTS-C in relation to metabolic signaling, cellular stress responses, and mitochondrial nuclear communication in preclinical systems. Its small size and endogenous origin make it a common target in mechanistic peptide research.
In Stock
BPC-157 + TB-500 – 10MG combines two widely discussed research peptides in a single 10 mg format. BPC-157 is a synthetic 15 amino acid peptide derived from a gastric protective protein fragment, while TB-500 refers to a thymosin beta 4 fragment commonly studied in peptide research. Researchers investigate this pairing in preclinical work involving connective tissue pathways, angiogenesis related signaling, and models of tissue repair and recovery.
In Stock
SS-31 10MG is a 10-milligram format of SS-31, a synthetic mitochondria targeted tetrapeptide also known as elamipretide. Researchers study SS-31 for its potential interactions with cardiolipin and mitochondrial membrane function in preclinical models. Studies have examined SS-31 in cellular and animal research involving bioenergetics and oxidative stress pathways.
In Stock
NAD 100MG is a 100-milligram format of nicotinamide adenine dinucleotide (NAD+), a ubiquitous pyridine nucleotide that participates in cellular redox reactions. Researchers study NAD+ in the context of mitochondrial metabolism, oxidative stress models, and enzyme systems such as sirtuins and PARPs.
In Stock
GHK-Cu 50MG is a 50-milligram format of copper peptide GHK-Cu, a coordination complex formed by the tripeptide glycyl-L-histidyl-L-lysine bound to Cu2+. Researchers study GHK-Cu in models involving skin biology, extracellular matrix signaling, and wound related pathways.
In Stock
